Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

FDA clears TAVR guidewire built with BASILICA in mind
The Telltale system was designed to assist cardiologists when BASILICA is required prior to TAVR.
New technique could help when cardiologists repair 2 leaky heart valves at once
Performing M-TEER and T-TEER on the same patient using a single guide catheter appears to be both safe and effective. Researchers shared their experience with this approach in Circulation: Cardiovascular Interventions.
‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations
The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
New physician Medicare payments for the Agent drug-coated balloon set for 2027
Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.

Valve-in-valve TMVR an effective option for patients with mitral prosthesis dysfunction

Adjusted mortality and perioperative complications were both lower among patients undergoing ViV TMVR.

'A substantial improvement’: New research shows signs of progress in PCI care

Inpatient care for PCI is trending in the right direction, researchers explained, but there is still room for improvement.

Is MCS necessary during high-risk PCI procedures?

Researchers aimed to gain a better understanding of a controversial topic.

First patients enrolled in clinical trial aimed at limiting unnecessary ICAs

The team behind the trial thinks this technology could help cut down on unnecessary invasive procedures.

CSI’s orbital atherectomy system debuts in Canada

An interventional cardiologist at Toronto General Hospital performed the procedures.

‘World’s smallest heart pump’ receives FDA’s breakthrough device designation

The FDA’s decision was based largely on clinical data from the first 21 patients to receive the device.

Right heart catheterization boosts outcomes for cardiogenic shock patients

Cardiogenic shock patients who underwent right heart catheterization had lower mortality and stroke rates during their index admission. An improvement was also seen in that group's 30-day readmission rate.

More data ‘urgently needed’ on link between coronary revascularization and cognitive decline

Should CABG and PCI patients be concerned about potential long-term cognitive issues? The current evidence is unclear.

Interventional Cardiology

FDA clears TAVR guidewire built with BASILICA in mind

New technique could help when cardiologists repair 2 leaky heart valves at once

‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

New physician Medicare payments for the Agent drug-coated balloon set for 2027